By Dr. Sanjay Kumar in CTVS at Paras Hospital Gurgaon, Paras Hospitals East & Patna.
Heart Procedure Dilemma: Decoding the Best Option — Why Surgery Still Matters
Reassessing the Role of Cardiovascular Surgery in Modern Heart Care
Despite dramatic advances in minimally invasive cardiology, cardiovascular surgery remains the gold standard in treating many forms of heart disease — especially when long-term outcomes, anatomical complexity, and overall patient stability are taken into account. In today’s fast-evolving medical landscape, procedures like bypass surgery, valve repair/replacement, and open aortic aneurysm repair continue to save lives, offering comprehensive and durable solutions that catheter-based methods often can’t fully match.
Heart disease remains the world’s leading cause of death, responsible for 17.9 million deaths annually (WHO), and a growing number of patients are being offered multiple procedural options. However, not all are created equal — and while minimally invasive techniques are appealing, surgical interventions are often the best, and sometimes the only, curative approach for certain conditions.
1. Bypass Surgery (CABG): The Cornerstone of Complex Coronary Disease Management
Coronary Artery Bypass Grafting (CABG) is one of the most time-tested and widely performed cardiovascular surgeries worldwide. It is the preferred approach for patients with:
-
- Left main coronary artery disease
-
- Triple-vessel disease
-
- Reduced heart function (low ejection fraction)
-
- Diabetes, especially with diffuse arterial involvement
Unlike angioplasty, which opens blocked arteries using stents, CABG reroutes blood flow entirely using grafts taken from the patient’s veins or arteries.
Why Surgery Still Wins:
-
- Long-term survival is superior in high-risk patients.
-
- Fewer repeat procedures are required compared to PCI.
-
- Allows simultaneous repair of other heart structures, like valves.
Key Evidence:
-
- The FREEDOM trial (NEJM, 2012) showed a 30% reduction in mortality with CABG over PCI in diabetic patients with multi-vessel disease.
-
- The SYNTAX trial found that patients with complex coronary lesions had significantly better 10-year outcomes with CABG.
2. Heart Valve Surgery: Durable Solutions Over Temporary Fixes
Surgical valve replacement or repair continues to be the most definitive treatment for moderate to severe valvular heart disease, particularly in younger patients or those with multiple valve or structural issues.
Surgical Valve Replacement (SAVR):
-
- Offers better durability, especially with mechanical valves that can last over 20 years.
-
- Can repair or replace multiple valves in a single procedure.
-
- Increasingly done using minimally invasive techniques, avoiding full sternotomy and speeding recovery.
Limitations of Transcatheter Options (TAVR/TMVR):
-
- TAVR, though popular, is best reserved for older patients or those at high surgical risk.
-
- TMVR (Transcatheter Mitral Valve Repair) is palliative, not curative, and unsuitable for many complex cases.
-
- Durability data for TAVR beyond 10–15 years remains unclear.
Supporting Data:
-
- A 2020 analysis in JACC reported higher reintervention rates after TAVR in younger, low-risk patients.
-
- Surgical valve replacement is associated with lower long-term complications, especially valve degeneration or need for reoperation.
3. Aortic Aneurysm Repair: When Surgery Is Still Essential
While Thoracic Endovascular Aortic Repair (TEVAR) has gained ground for treating certain aortic aneurysms, open surgical repair remains vital for patients with:
-
- Ascending or arch aneurysms
-
- Connective tissue disorders (e.g., Marfan syndrome)
-
- Anatomical contraindications for stenting
Why Open Repair Still Matters:
-
- It provides definitive repair with long-term graft stability.
-
- Avoids issues like endoleaks, which affect up to 20% of TEVAR patients.
-
- Hybrid surgeries are expanding options, combining open and endovascular methods, but surgery still leads in durability.
Key Stats:
-
- Open repair 30-day mortality: ~8%, but with superior durability in low-risk patients.
- TEVAR has short-term benefits but requires lifelong imaging and carries risk of device-related complications.
Surgery in the Era of Evidence-Based Medicine
Today’s cardiovascular surgeons don’t just perform procedures — they lead heart teams, analyse complex cases, and help patients make informed, data-driven choices. In an era of growing emphasis on quality of life, durability, and cost-effectiveness, surgery often provides the most reliable, curative outcome, particularly in:
-
- Younger patients
-
- Noncompliant patients who may not adhere to post-procedure medications
-
- Complex anatomical scenarios where catheter-based techniques fall short
Minimally invasive surgical options — such as small incision valve replacements or robot-assisted bypass surgery — have further enhanced the role of surgery by reducing recovery time and patient discomfort, while maintaining clinical superiority.
Final Word: The Surgical Advantage
While less invasive options like PCI and TAVR are increasingly used, surgery remains the foundation of cardiovascular care in many cases. The decision must be personalised, balancing short-term comfort with long-term outcomes and risk reduction.
Cardiovascular surgery is not just an alternative — in many cases, it’s the answer